Magnus Stack for cutting: GW501516+SR9009

Magnus Stenabolic (SR9009)

Magnus Stenabolic (SR9009), a synthetic Rev-Erb ligand that is consumed orally, is a comparatively rare compound. Because it stimulates the Rev-Erb protein, SR9009 can significantly alter multiple regulatory processes in the body. This encompasses elements such as metabolic rate, fat storage, circadian rhythm, as well as macrophages. As a result of taking Stenabolic, the user can benefit from increased loss of fat and increased stamina - two highly sought-after qualities for any sportsperson.

Magnus Endurobol (GW501516)

Magnus Endurobol (GW501516) is thought of as a possible cure for obesity because of its capacity to burn fat by stimulating glucose absorption and fatty acid oxidation in muscle mass. Research has demonstrated that Cardarine can raise the HDL (good cholesterol) levels by 79%, as well as reduce LDL (bad cholesterol) in current Phase II trials. GW 501516 is a PPARδ agonist which boosts HDL levels due to an improvement of the cholesterol transporter ABCA1.

Over the past two decades, no adverse effects have been reported by anyone conducting research on the medicine.

GW 501516 & Cancer

Many forum comments have brought up worries about GW501516 and if it is linked to cancer and tumor development. This controversy started from GW’s capability to drastically increase angiogenesis in the body, which is the process of the body producing more blood vessels to nourish the cells. It is suspected that this could be related to the elevated incidence of cancer in lab mice colons.

It has been frequently noted that endurance athletes and adolescents tend to be more prone to tumor cell activity in the body. Scientists assumed that the active tumor cells would make them very susceptible to angiogenesis leading to accelerated tumor growth. Subsequently, experiments have been carried out since 2004 in order to ascertain the accuracy of this idea, however none of them have been successful.